RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
13.710 |
Evidence |
O
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
13.680 |
Evidence |
O
|
TGFBR2 |
TGFBR2: TGF-beta receptor type-2 precursor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
13.670 |
Evidence |
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
13.570 |
Evidence |
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
13.570 |
Evidence |
|
TCF8 |
ZEB1, AREB6, TCF8: Zinc finger E-box-binding homeobox 1 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
13.570 |
Evidence |
O
|
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
13.550 |
Evidence |
|
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
13.550 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
13.550 |
Evidence |
|
SSH2 |
SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 |
CFL1 |
CFL1, CFL: Cofilin-1 |
13.550 |
Evidence |
|
FGG |
FGG, PRO2061: Fibrinogen gamma chain precursor |
ITGB3 |
ITGB3, GP3A: Integrin beta-3 precursor |
13.550 |
Evidence |
|
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
13.550 |
Evidence |
|
HNRPD |
HNRPD, AUF1: Heterogeneous nuclear ribonucleoprotein D0 |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
13.550 |
Evidence |
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
13.550 |
Evidence |
|
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
JAK1 |
|
13.550 |
Evidence |
|
CRKL |
CRKL: Crk-like protein |
SOS1 |
SOS1: Son of sevenless homolog 1 |
13.510 |
Evidence |
O
|
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
CDKN1B |
CDKN1B, KIP1: Cyclin-dependent kinase inhibitor 1B |
13.510 |
Evidence |
O
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
STAT3 |
|
13.490 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
13.490 |
Evidence |
|
CDC2 |
CDC2: Cell division control protein 2 homolog |
CCNB1 |
Cyclin B1 |
13.490 |
Evidence |
O
|
YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
13.490 |
Evidence |
|
PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
CCNB1 |
Cyclin B1 |
13.490 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
13.490 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
STAT3 |
|
13.490 |
Evidence |
|
CDC2 |
CDC2: Cell division control protein 2 homolog |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
13.490 |
Evidence |
|